The Board of Directors of Milestone Medical, Inc. (WAR:MMD, "the Company", "the Issuer”) informs of withdrawal of its application for admission and introduction to trading on the regulated market operated by the Warsaw Stock Exchange of existing 22 000 000 shares of common stock.
The Issuer has filed with the Polish Financial Supervision Authority updating communication to the Prospectus containing information about withdrawal from the transmission of the Company's shares to the regulated market operated by the Warsaw Stock Exchange. The updating communication was also published on the website of the Issuer.
Legal basis: Article 56 sec. 1 point 1) of the Act on Public Offering.
Osoby reprezentujące spółkę:
Joseph D'Agostino - Chief Financial Officer